(Q41526076)

2 October 2017

1 reference

title

Cholesterol screening should be targeted (English)

1 reference

2 October 2017

A M Garber

1

1 reference

2 October 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

American Journal of Medicine

2 October 2017

published in

1 reference

2 October 2017

volume

102

1 reference

2 October 2017

issue

2A

1 reference

2 October 2017

page(s)

26-30

1 reference

Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. American College of Physicians. Part 1

2 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900464-6

Cholesterol screening in asymptomatic adults, revisited. Part 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900464-6

Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900464-6

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900464-6

Total Serum Cholesterol Levels and Mortality Risk as a Function of Age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900464-6

Cholesterol and mortality. 30 years of follow-up from the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900464-6

A single cholesterol measurement underestimates the risk of coronary heart disease. An empirical example from the Lipid Research Clinics Mortality Follow-up Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900464-6

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900464-6

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900464-6

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900464-6

Blood pressure, stroke, and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900464-6

Dietary reduction of serum cholesterol concentration: time to think again

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900464-6

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900464-6

10.1016/S0002-9343(97)00464-6

7 January 2021

Identifiers

DOI

1 reference

2 October 2017

1 reference